BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16336420)

  • 1. The links between diabetes and cardiovascular disease.
    Schnell O
    J Interv Cardiol; 2005 Dec; 18(6):413-6. PubMed ID: 16336420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A
    Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical implications of impaired glucose tolerance.
    Alberti KG
    Diabet Med; 1996 Nov; 13(11):927-37. PubMed ID: 8946150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequacies of absolute threshold levels for diagnosing prediabetes.
    Bergman M
    Diabetes Metab Res Rev; 2010 Jan; 26(1):3-6. PubMed ID: 20101658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative oral glucose tolerance testing in vascular surgery patients: long-term cardiovascular outcome.
    van Kuijk JP; Dunkelgrun M; Schreiner F; Flu WJ; Galal W; van Domburg RT; Hoeks SE; van Gestel YR; Bax JJ; Poldermans D
    Am Heart J; 2009 May; 157(5):919-25. PubMed ID: 19376322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose and cardiovascular risk.
    Fuchs M; Hoekstra JB; Mudde AH
    Neth J Med; 2002 Jun; 60(5):192-9. PubMed ID: 12365474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
    Roman G; Hancu N
    Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary and perspectives on impaired glucose tolerance.
    Genuth S
    Diabet Med; 1996; 13(3 Suppl 2):S29-31. PubMed ID: 8689860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.
    Anselmino M; Mellbin L; Wallander M; Rydén L
    Rev Cardiovasc Med; 2008; 9(1):29-38. PubMed ID: 18418307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glucose tolerance, diabetes, and cardiovascular disease.
    Schnell O; Standl E
    Endocr Pract; 2006; 12 Suppl 1():16-9. PubMed ID: 16627374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies in ongoing clinical trials to reduce cardiovascular disease in patients with diabetes mellitus and insulin resistance.
    Mazzone T
    Am J Cardiol; 2004 Jun; 93(11A):27C-31C. PubMed ID: 15178514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A; Moore RH; Baboolal K
    Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, prediabetes and cardiovascular risk.
    Mellbin LG; Anselmino M; Rydén L
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S9-14. PubMed ID: 20489420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance.
    Marchesini G; Ronchi M; Forlani G; Bugianesi E; Bianchi G; Fabbri A; Zoli M; Melchionda N
    Am J Gastroenterol; 1999 Mar; 94(3):655-62. PubMed ID: 10086647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
    Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
    Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.